Alligator Bioscience: Infocus interview with CEO Sören Bergenholt at Redeye Life Science Day 2022
Alligator Bioscience gains orphan designation for mitazalimab - PharmaTimes
Alligator Bioscience restructures - Nordic Life Science – the leading Nordic life science news service
Alligator Bioscience (@AlligatorBio) / X
Alligator Bioscience extends collaboration with Orion Corporation - BioStock
Alligator Bioscience AB - Redeye
Alligator Bioscience (ATORX) - Technische Analyse - Stockholmsbörsen - Investtech
Alligator Bioscience KOL Event: Improving Efficacy and Prolonging Survival in Pancreatic Cancer – A Look into Mitazalimab Interim Data from the OPTIMIZE-1 Phase 2 Study - LifeSci Events
Alligator Bioscience and Aptevo Therapeutics Announce that FDA has Issued a “May Proceed” Notification for the ALG.APV-527 IND – Alligator Bioscience
Søren Bregenholt on LinkedIn: Alligator Bioscience KOL Event: Improving Efficacy and Prolonging Survival…
Fundamentaldaten Alligator Bioscience AB
Alligator Bioscience AB Aktie
Alligator Bioscience investerar i sin pipeline - BioStock
Alligator Bioscience - Carnegie
Vator Securities | News
Alligator Bioscience enters research collaboration - Nordic Life Science – the leading Nordic life science news service
Frontier – A Magazine about Alligator Bioscience and Immuno-oncology – Alligator Bioscience
Alligator Bioscience (@AlligatorBio) / X
Alligator Bioscience: About the company
Alligator Bioscience Q4 Report 2021
Alligator Bioscience AB | LinkedIn
Alligator Bioscience COO Malin Carlsson presents at Redeye Orphan Drugs Event – April 26, 2023
